COPD is an indipendent risk factor for in-situ pulmonary artery thrombosis

P. Intiglietta (bari, Italy), M. Peragine (Acquaviva delle Fonti, Italy), P. Buonamico (bari, Italy), G. Castellana (Cassano delle Murge, Italy), O. Resta (bari, Italy)

Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Session: Pulmonary embolism: from diagnosis to prognosis and treatment
Session type: Poster Discussion
Number: 3649
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Intiglietta (bari, Italy), M. Peragine (Acquaviva delle Fonti, Italy), P. Buonamico (bari, Italy), G. Castellana (Cassano delle Murge, Italy), O. Resta (bari, Italy). COPD is an indipendent risk factor for in-situ pulmonary artery thrombosis. 3649

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Factors predicting pulmonary artery pressure after acute pulmonary thromboembolism
Source: Eur Respir J 2001; 18: Suppl. 33, 380s
Year: 2001

Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005


Is intracardiac thrombus a risk factor for the development of pulmonary artery aneurysm in behcet disease?
Source: Eur Respir J 2002; 20: Suppl. 38, 63s
Year: 2002

Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012



Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Risk of deep vein thrombosis and pulmonary embolism in asthma
Source: Eur Respir J 2013; 42: 655-661
Year: 2013



Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020


Prediction of outcome after PEA in chronic thromboembolic pulmonary hypertension using indexed pulmonary artery diameter
Source: Eur Respir J 2014; 43: 909-912
Year: 2014


Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


Fatal dissection of the pulmonary artery in pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 181-185
Year: 2009



The development of pulmonary hypertension after first episode of acute pulmonary embolism and related risk factors
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Venous thromboemboli and exacerbations of COPD
Source: Eur Respir J 2010; 35: 1243-1248
Year: 2010



Chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Update on venous thromboembolism
Year: 2007


Chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2004; 23: 637-648
Year: 2004



Fibrinogen AaThr312Ala polymorphism predisposes to chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Acute and chronic pulmonary embolism
Year: 2007


Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases
Year: 2019


Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019



Clinical presentation and outcome of venous thromboembolism in COPD
Source: Eur Respir J 2012; 39: 862-868
Year: 2012



A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development
Source: Eur Respir J 2003; 22: Suppl. 45, 221s
Year: 2003